本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Roivant Sciences Ltd.

10.64
-0.3900-3.54%
盘后10.51-0.1267-1.19%19:47 EDT
成交量:673.58万
成交额:7,301.24万
市值:75.92亿
市盈率:-68.35
高:11.17
开:11.04
低:10.62
收:11.03
数据加载中...
2022/06/28

重要事件披露

8-K - Current report
2022/06/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/06/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/24

重要事件披露

8-K - Current report
2022/03/31

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/03/30

重要事件披露

8-K - Current report
2022/03/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/02/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/02/28

重要事件披露

8-K - Current report
2022/02/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/02/17

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/02/14

重要事件披露

8-K - Current report
2022/02/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/30

SEC问询函

CORRESP [Cover] - Correspondence